Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Cash from Operations (2020 - 2026)

Biomea Fusion (BMEA) posted Cash from Operations of 11669000.0 for Q1 2026, up 16.3% sequentially from 13942000.0 in Q4 2025, and up 54.54% YoY from 7550944.74 in Q1 2025.

Biomea Fusion (BMEA) Cash from Operations (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Cash from Operations for 7 years, with the latest figure at 11669000.0 in Q1 2026.

  • Quarterly Cash from Operations rose 54.54% year-over-year to 11669000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56373000.0 (up 50.35% YoY) and the FY2025 annual result came in at 70371000.0, up 41.31% from the prior year.
  • Cash from Operations advanced to 11669000.0 in Q1 2026 per BMEA's latest filing, from 13942000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 9994000.0 in Q1 2022 and troughed at 32643000.0 in Q2 2024.
  • A 5-year average of 21231941.18 and a median of 22837000.0 in 2023 frame the typical range for Cash from Operations.
  • The sharpest annual moves came in 2022 and 2026: Cash from Operations tumbled 145.25% in 2022, then jumped 54.54% in 2026.
  • Over 5 years, Cash from Operations stood at 20201000.0 in 2022, then dropped by 13.05% to 22837000.0 in 2023, then tumbled by 31.38% to 30004000.0 in 2024, then soared by 53.53% to 13942000.0 in 2025, then climbed by 16.3% to 11669000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 11669000.0, 13942000.0, and 11550000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -526.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 462.82 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 326.72 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 360.27 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -88.83 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 728.46 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -10.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.03 Mn
Jun 30, 2026 -10.03 Mn
Mar 31, 2026 -11.67 Mn
Mar 31, 2026 -11.67 Mn
Dec 31, 2025 -13.94 Mn
Dec 31, 2025 -13.94 Mn
Sep 30, 2025 -11.55 Mn
Sep 30, 2025 -11.55 Mn
Jun 30, 2025 -19.21 Mn
Jun 30, 2025 -19.21 Mn
Mar 31, 2025 -25.67 Mn
Mar 31, 2025 -25.67 Mn
Dec 31, 2024 -30.00 Mn
Dec 31, 2024 -30.00 Mn
Sep 30, 2024 -25.22 Mn
Sep 30, 2024 -25.22 Mn
Jun 30, 2024 -32.64 Mn
Jun 30, 2024 -32.64 Mn
Mar 31, 2024 -32.03 Mn
Mar 31, 2024 -32.03 Mn